1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Asia Pacific Radiotherapy Market Outlook - Forecast (2014-2020)

Hoovers Research analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis.

This report analyzes the markets for “Radiotherapy“. The report provides the standard and the tailored research methodology approach. The market overview offers in depth analysis for the regional and country level analysis, for instance Asia-Pacific (China, Japan, India, South Korea and Rest of APAC). Annual estimations and forecasts are provided from the year 2012 to 2020 for each given segments and sub segments. Market data derived from the authenticated and reliable sources subjected to validation from the industry experts. The report also analyzes the market by discussing market dynamics such as drivers, constraints, opportunities, threats, challenges and other market trends.
Competitive landscaping provides the recent activities performed by the active players in the market. Activities such as product launch, agreements, joint ventures, partnerships, acquisitions and mergers, other activities.

This report provides:
- Market forecasts for a minimum of 5 years of all the mentioned segments, sub segments and the regional markets
- Identifying market dynamics (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Regional and country level market analysis
- Competitive landscaping mapping the key common trends
- Company profiling covering the financials, recent activities and the future strategies
- Supply chain trends mapping the recent advancements
- Market share assessments of the top players along with strategic recommendations for the new entrants

Table Of Contents

Asia Pacific Radiotherapy Market Outlook - Forecast (2014-2020)
1 Introduction
1.1 Scope of the Report
1.2 Report Description
1.3 Research Methodology
1.4 Research Sources
1.4.1 Secondary Research
1.4.2 Primary Research
1.4.3 Assumptions
1.5 List of Abbreviations

2 Executive Summary

3 Market Analysis
3.1 Market Segmentation
3.2 Market Size Estimation
3.3 Market Drivers
3.3.1 Strong Network of the major players
3.3.2 Wide range of product offerings
3.3.3 Increasing usage of Chocolate as a Functional Food
3.4 Market Constraints
3.4.1 Supply Dependency On West African Countries For Cocoa
3.4.2 Sluggish growth in Developed regions
3.4.3 Rapidly changing end user preferences

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Radiotherapy Market by Product Type
5.1 Non-Ionizing Radiation
5.2 Ionizing Radiation
5.3 Particle Radiation
5.4 Electron Beams
5.5 Proton Beams
5.6 Neutron Beams
5.7 Carbon Ions
5.8 Alpha and Beta Particles
5.9 Photon Radiations
5.10 Gamma Rays
5.11 X-rays

6 Radiotherapy Market by Technology
6.1 Intensity Modulated Radiation Therapy (IMRT)
6.2 3-D Conformal Radiotherapy (3D CRT)
6.3 Proton Beam Therapy
6.4 Stereotactic Technology
6.5 Tomotherapy
6.6 Adaptive Radiation Therapy
6.7 Systemic Radiation Therapy

7 Radiotherapy Market by Application
7.1 Lung Cancer
7.2 Colorectal Cancer
7.3 Prostate Cancer
7.4 Breast Cancer
7.5 Head and Neck Cancer
7.6 Brain Cancer
7.7 Spine Cancer
7.8 Cervical Cancer

8 Geographical Segmentation
8.1 Asia Pacific
8.1.1 Japan
8.1.2 China
8.1.3 India
8.1.4 Australia
8.1.5 Newzealand
8.1.6 Rest of Asia Pacific

9 Vendor Landscaping
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions and Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiles
10.1 Varian Medical Systems
10.1.1 Business Overview
10.1.2 SWOT Analysis
10.1.3 Financial Overview
10.1.4 Strategy
10.1.5 Key Activities
10.2 Siemens Healthcare
10.3 Nordion, Inc
10.4 IBA Group
10.5 GE Healthcare
10.6 Covidien, Plc
10.7 Cardinal Health, Inc.
10.8 Accuray, Inc.
10.9 ANSTO
10.10 C. R. Bard, Inc.
11 Appendix
12 Disclaimer

List of Exhibits
Table 1 Asia Pacific Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 2 Asia Pacific Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 3 Asia Pacific Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 4 Asia Pacific Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 5 Asia Pacific Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 6 Asia Pacific Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 7 Asia Pacific Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 8 Asia Pacific Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 9 Asia Pacific Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 10 Asia Pacific Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 11 Asia Pacific Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 12 Asia Pacific Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 13 Asia Pacific Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 14 Asia Pacific Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 15 Asia Pacific Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 16 Asia Pacific Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 17 Asia Pacific Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 18 Asia Pacific Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 19 Asia Pacific Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 20 Asia Pacific Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 21 Asia Pacific Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 22 Asia Pacific Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 23 Asia Pacific Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 24 Asia Pacific Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 25 Asia Pacific Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 26 Asia Pacific Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 27 Asia Pacific Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 28 Asia Pacific Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 29 Asia Pacific Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 30 Asia Pacific Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN) Japan
Table 31 Japan Radiotherapy Market Analysis, by Region, 2013-2020 ($MN) China
Table 32 Japan Radiotherapy Market Analysis, by Product, 2013-2020 ($MN) India
Table 33 Japan Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN) Australia
Table 34 Japan Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN) Newzealand
Table 35 Japan Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN) Rest of Asia Pacific
Table 36 Japan Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 37 Japan Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 38 Japan Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 39 Japan Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 40 Japan Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 41 Japan Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 42 Japan Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 43 Japan Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 44 Japan Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 45 Japan Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 46 Japan Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 47 Japan Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 48 Japan Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 49 Japan Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 50 Japan Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 51 Japan Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 52 Japan Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 53 Japan Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 54 Japan Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 55 Japan Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 56 Japan Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 57 Japan Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 58 Japan Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 59 Japan Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 60 Japan Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 61 China Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 62 China Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 63 China Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 64 China Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 65 China Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 66 China Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 67 China Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 68 China Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 69 China Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 70 China Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 71 China Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 72 China Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 73 China Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 74 China Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 75 China Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 76 China Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 77 China Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 78 China Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 79 China Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 80 China Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 81 China Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 82 China Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 83 China Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 84 China Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 85 China Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 86 China Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 87 China Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 88 China Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 89 China Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 90 China Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 91 India Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 92 India Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 93 India Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 94 India Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 95 India Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 96 India Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 97 India Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 98 India Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 99 India Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 100 India Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 101 India Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 102 India Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 103 India Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 104 India Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 105 India Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 106 India Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 107 India Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 108 India Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 109 India Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 110 India Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 111 India Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 112 India Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 113 India Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 114 India Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 115 India Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 116 India Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 117 India Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 118 India Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 119 India Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 120 India Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 121 Australia Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 122 Australia Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 123 Australia Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 124 Australia Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 125 Australia Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 126 Australia Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 127 Australia Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 128 Australia Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 129 Australia Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 130 Australia Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 131 Australia Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 132 Australia Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 133 Australia Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 134 Australia Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 135 Australia Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 136 Australia Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 137 Australia Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 138 Australia Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 139 Australia Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 140 Australia Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 141 Australia Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 142 Australia Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 143 Australia Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 144 Australia Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 145 Australia Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 146 Australia Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 147 Australia Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 148 Australia Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 149 Australia Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 150 Australia Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 151 New Zealand Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 152 New Zealand Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 153 New Zealand Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 154 New Zealand Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 155 New Zealand Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 156 New Zealand Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 157 New Zealand Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 158 New Zealand Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 159 New Zealand Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 160 New Zealand Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 161 New Zealand Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 162 New Zealand Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 163 New Zealand Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 164 New Zealand Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 165 New Zealand Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 166 New Zealand Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 167 New Zealand Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 168 New Zealand Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 169 New Zealand Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 170 New Zealand Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 171 New Zealand Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 172 New Zealand Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 173 New Zealand Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 174 New Zealand Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 175 New Zealand Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 176 New Zealand Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 177 New Zealand Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 178 New Zealand Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 179 New Zealand Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 180 New Zealand Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)
Table 181 Rest of APAC Radiotherapy Market Analysis, by Region, 2013-2020 ($MN)
Table 182 Rest of APAC Radiotherapy Market Analysis, by Product, 2013-2020 ($MN)
Table 183 Rest of APAC Radiotherapy Market Analysis, by Non-Ionizing Radiation, 2013-2020 ($MN)
Table 184 Rest of APAC Radiotherapy Market Analysis, by Ionizing Radiation, 2013-2020 ($MN)
Table 185 Rest of APAC Radiotherapy Market Analysis, by Particle Radiation, 2013-2020 ($MN)
Table 186 Rest of APAC Radiotherapy Market Analysis, by Electron Beams, 2013-2020 ($MN)
Table 187 Rest of APAC Radiotherapy Market Analysis, by Proton Beams, 2013-2020 ($MN)
Table 188 Rest of APAC Radiotherapy Market Analysis, by Neutron Beams, 2013-2020 ($MN)
Table 189 Rest of APAC Radiotherapy Market Analysis, by Carbon Ions, 2013-2020 ($MN)
Table 190 Rest of APAC Radiotherapy Market Analysis, by Alpha and Beta Particles, 2013-2020 ($MN)
Table 191 Rest of APAC Radiotherapy Market Analysis, by Photon Radiations, 2013-2020 ($MN)
Table 192 Rest of APAC Radiotherapy Market Analysis, by Gamma Rays, 2013-2020 ($MN)
Table 193 Rest of APAC Radiotherapy Market Analysis, by X-rays, 2013-2020 ($MN)
Table 194 Rest of APAC Radiotherapy Market Analysis, by Technology, 2013-2020 ($MN)
Table 195 Rest of APAC Radiotherapy Market Analysis, by Intensity Modulated Radiation Therapy (IMRT), 2013-2020 ($MN)
Table 196 Rest of APAC Radiotherapy Market Analysis, by 3-D Conformal Radiotherapy (3D CRT), 2013-2020 ($MN)
Table 197 Rest of APAC Radiotherapy Market Analysis, by Proton Beam Therapy, 2013-2020 ($MN)
Table 198 Rest of APAC Radiotherapy Market Analysis, by Stereotactic Technology, 2013-2020 ($MN)
Table 199 Rest of APAC Radiotherapy Market Analysis, by Tomotherapy, 2013-2020 ($MN)
Table 200 Rest of APAC Radiotherapy Market Analysis, by Adaptive Radiation Therapy, 2013-2020 ($MN)
Table 201 Rest of APAC Radiotherapy Market Analysis, by Systemic Radiation Therapy, 2013-2020 ($MN)
Table 202 Rest of APAC Radiotherapy Market Analysis, by Application, 2013-2020 ($MN)
Table 203 Rest of APAC Radiotherapy Market Analysis, by Lung Cancer, 2013-2020 ($MN)
Table 204 Rest of APAC Radiotherapy Market Analysis, by Colorectal Cancer, 2013-2020 ($MN)
Table 205 Rest of APAC Radiotherapy Market Analysis, by Prostate Cancer, 2013-2020 ($MN)
Table 206 Rest of APAC Radiotherapy Market Analysis, by Breast Cancer, 2013-2020 ($MN)
Table 207 Rest of APAC Radiotherapy Market Analysis, by Head and Neck Cancer, 2013-2020 ($MN)
Table 208 Rest of APAC Radiotherapy Market Analysis, by Brain Cancer, 2013-2020 ($MN)
Table 209 Rest of APAC Radiotherapy Market Analysis, by Spine Cancer, 2013-2020 ($MN)
Table 210 Rest of APAC Radiotherapy Market Analysis, by Cervical Cancer, 2013-2020 ($MN)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Hematological Cancers: Analytical Tool

Hematological Cancers: Analytical Tool

  • $ 11505
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Glioblastoma Multiforme - Cancer Immunotherapies Dominate First-in-Class Product Innovation Summary Glioblastoma multiforme (GBM) is a grade IV tumor that arises from astrocytes. It is ...

Drugs and Diagnostics for Hematological Disorders: Global Markets

Drugs and Diagnostics for Hematological Disorders: Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Receive detailed information regarding screening, testing and treatment options for hematological disorders and blood cancer. - Learn about the types of diagnostic and treatment ...

Lung Cancer: Analytical Tool

August 2016 $ 8096

Ovarian Cancer: Analytical Tool

August 2016 $ 8096

Renal Cancer: Analytical Tool

August 2016 $ 8096

Bladder Cancer: Analytical Tool

August 2016 $ 8096

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.